Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
11 August 2022 | Story NONSINDISO QWABE | Photo SUPPLIED
The erudite watchmaker, Jabulani Mabuza.

At a time when it is becoming fashionable for high-tech smartwatches and fitness gadgets to adorn your wrist, there will always be room for a classic timepiece. Wristwatches in particular tell a different story to people of all social classes, and for Qwaqwa student Jabulani Mabuza, the process of making different watches to suit different tastes is what excites him the most.

Mabuza is in his final year of a BCom General Management degree.  In January 2020, he acted on his curiosity about the process of assembling a watch, and subsequently registered his watch business, Honour Watches, in January 2021.
Since then, he has steadily honed his craft, learning more about the art of watches. He recently made it through to the central regional rounds of the Entrepreneurship Development in Higher Education (EDHE) competition in the Existing Businesses category for studentpreneurs. 

On the pursuit of mastering the art of watchmaking

Horology is the study and measurement of time. It is the process of allowing yourself the time and patience required to master the art of building a watch from scratch, and Mabuza said he enjoyed the intricacies of the watchmaking process. “What I enjoy about horology is learning the deeper technicalities of the art, the whole process – from understanding basic astronomy and how planets move in our solar system, to sort of emulating that in a watch mechanism. The working of metals transformed into watch components that actually tell time, is what I enjoy most and what I am investing in so that I can master it one day,” he said.

As a BCom student, he said his studies have largely influenced his business journey, as it helps him understand the structure of his business professionally. “It assists me with the business administration and management of Honour, and the rest is inspired by my creativity and passion for what time means to human beings.”

Mabuza said South Africa does not have a watchmaking plant as yet, so all the components for his watches are currently imported from Japan and Switzerland. He hopes to one day have his own production plant that will produce watches from scratch, in order to teach more people this skill and to create jobs, for which there is always a need. Currently, he studies the watch components to learn which movement best complements which type of hand and casing, in order to assemble them according to the designs he likes. 

“I enjoy the pursuit of creating a mechanical auto-magnetic watch for international travellers that will automatically adjust to different time zones as they travel. These horological pursuits are what I enjoy the most, believe in, and am passionate about.”

The regional rounds will be held on the UFS Bloemfontein Campus from 19 to 23 September 2022.

News Archive

Nano research at the UFS opens door to smart drugs
2011-06-27

 

Prof. Lodewyk Kock, outstanding professor in our Department of Microbial, Biochemical and Food Biotechnology

Novel antifungal, anticancer and anti-malaria drugs that have been identified in the research of Prof. Lodewyk Kock, outstanding professor in the Department of Microbial, Biochemical and Food Biotechnology at our university, will be disclosed later this year at major international conferences in Asia, Europe and the USA. Prof. Kock will be the keynote speaker at these conferences. 

His presentations will be based on the department’s discovery of yeast assays linked to a new nanotechnology for medicine. The assays were recently discovered by his group and can be applied in the development of novel antifungal, anticancer and anti-malaria drugs.
 
Prof. Kock’s focused research at the university, which now also includes his novel nanotechnology for Biology, began in 1982 in collaboration with Prof. Pieter van Wyk (Centre for Microscopy). He recently collaborated with Prof. Hendrik Swart (Department of Physics).
 
Prof. Kock says the development of novel anti-malaria drugs in particular is getting attention across the world due to the high rates of morbidity and mortality caused by the disease worldwide. Approximately 225 million people are infected annually and about a million (many in Africa) die each year. “Many potential smart drugs have been identified with this research and should now be tested further,” says Kock.
  
These new drugs will be disclosed during Prof. Kock’s keynote addresses at the International Conference and Exhibition on Pharmaceutical Regulatory Affairs in Baltimore, USA, from 6 to 7 September 2011, the Medichem 2011 in Beijing, China from 9 to 11 August 2011 and the XVI Congress of European Mycologists in Greece, from 19 to 23 September 2011.

 

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept